DOMO Cover Image
Reflecting On Data Analytics Stocks’ Q4 Earnings: Domo (NASDAQ:DOMO)

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Domo (NASDAQ:DOMO) and the rest of the data analytics stocks fared in Q4.

Organizations generate a lot of data that is stored in silos, often in incompatible formats, making it slow and costly to extract actionable insights, which in turn drives demand for modern cloud-based data analysis platforms that can efficiently analyze the siloed data.

The 5 data analytics stocks we track reported a strong Q4. As a group, revenues beat analysts’ consensus estimates by 2.5% while next quarter’s revenue guidance was in line.

Amidst this news, share prices of the companies have had a rough stretch. On average, they are down 14.1% since the latest earnings results.

Founded by Josh James after selling his former business Omniture to Adobe, Domo (NASDAQ:DOMO) provides business intelligence software that allows managers to access and visualize critical business metrics in real-time, using their smartphones.

Domo reported revenues of $78.77 million, down 1.8% year on year. This print exceeded analysts’ expectations by 1%. Overall, it was a very strong quarter for the company with a solid beat of analysts’ billings estimates and EPS guidance for next quarter exceeding analysts’ expectations.

Domo Total Revenue
Domo Total Revenue

Domo delivered the slowest revenue growth of the whole group. The stock is up 6.1% since reporting and currently trades at $7.49.

Is now the time to buy Domo? Access our full analysis of the earnings results here, it’s free.

Started by Peter Thiel after seeing US defence agencies struggle in the aftermath of the 2001 terrorist attacks, Palantir (NYSE:PLTR) offers software as a service platform that helps government agencies and large enterprises use data to make better decisions.

Palantir reported revenues of $827.5 million, up 36% year on year, outperforming analysts’ expectations by 6.8%. The business had an exceptional quarter with a solid beat of analysts’ billings estimates and an impressive beat of analysts’ EBITDA estimates.

Palantir Total Revenue
Palantir Total Revenue

Palantir delivered the biggest analyst estimates beat, fastest revenue growth, and highest full-year guidance raise among its peers. Although it had a fine quarter compared to its peers, the market seems unhappy with the results as the stock is down 4% since reporting. It currently trades at $80.57.

Is now the time to buy Palantir? Access our full analysis of the earnings results here, it’s free.

Founded by healthcare professionals Tom Burton and Steve Barlow in 2008, Health Catalyst (NASDAQ:HCAT) provides data and analytics technology to healthcare organizations, enabling them to improve care and lower costs.